The authors of the 2016 Examination of MDMA, released while in the Journal of Psychopharmacology, concluded which the drug “offers a promising treatment for PTSD.”Traders and researchers have doubled down to the sector in recent times and funneled billions into drugs like psilocybin, ketamine, and LSD. Insiders don’t watch the FDA dust-up as